Palatin Awarded “Top 10 Poster” Designation at the American Society of Retina Specialists (ASRS) 2021 Annual Meeting
ASRS Top 10 awarded to Palatin’s pre-clinical diabetic retinopathy poster demonstrating positive effects of melanocortin agonists for retinal inflammation Oct 22, 2021, 07:30 ET CRANBURY, N.J., Oct. 22, 2021 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide …